MRNA Stock Analysis: Buy, Sell, or Hold?
MRNA - Moderna, Inc. Common Stock
$140.34
2.35 (1.70%)
▲
5d:
+1.04%
30d:
+156.0%
90d:
+204.69%
WAIT
LOW Confidence
Analysis Updated: Aug 31, 2026 12:00 AM ET
Earnings: Jul 31, 2026
0d
Smart Money Distribution
Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →
Signal fired Aug 24, 2026 at $138.93 · last confirmed Aug 31, 2026
Strength: 9.0/10
Get Alerted When MRNA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: MRNA shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: MRNA shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: MRNA is currently trading at $140.34, which is considered extended relative to its 30-day fair value range of $44.87 to $128.77.
Technical Outlook: Technically, MRNA is in a uptrend. Immediate support is located at $62.13, while resistance sits at $176.66.
Market Sentiment: MRNA scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $106.62. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MRNA is in a uptrend. Immediate support is located at $62.13, while resistance sits at $176.66.
Market Sentiment: MRNA scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $106.62. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$44.87 -
$128.77
Company Quality Score
36/100
(SELL)
Volume Confirmation
MODERATE
Confidence Score
5.3%
Protect Your Profits
Holding MRNA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+9.0% above its trading range)
- BEARISH: Weak technical setup (0/100)
- BEARISH: Trading 24.0% above Wall St target ($106.62)
- WARNING: Composite score 36/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$44.87 -
$128.77
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$62.13
Resistance Level
$176.66
Current Trend
Uptrend
Technical data as of
Aug 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-28.17
Wall Street Target
$106.63
(-24.0%)
Revenue Growth (YoY)
2.1%
Earnings Growth (YoY)
-85.1%
Profit Margin
-141.4%
Share & Embed Analysis
Last updated: September 01, 2026 3:55 AM ET
Data refreshes hourly during market hours. Next update: 4:55 AM
Data refreshes hourly during market hours. Next update: 4:55 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MRNA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 46 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$127 | 52 HOLD |
|
RNA
Atrium Therapeutics, Inc… |
STRONG BUY
15 analysts |
$25 | 49 HOLD |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$37 | 47 HOLD |
|
MIRM
Mirum Pharmaceuticals Inc |
STRONG BUY
10 analysts |
$138 | 59 HOLD |
Advanced MRNA Option Strategies
Professional options setups generated by AI based on today's MRNA price and gamma walls.
